|
|
|
Volumn 16, Issue 5 I, 1996, Pages 969-
|
|
Withdrawal syndrome is not precipitated when butorphanol is added to opiate or opioid therapy. A comment on intranasal butorphanol-induced apraxia reversed by naloxone
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BUTORPHANOL;
CODEINE;
FENTANYL;
HYDROCODONE;
HYDROMORPHONE;
KAPPA OPIATE RECEPTOR;
LEVORPHANOL;
MORPHINE;
MU OPIATE RECEPTOR;
NALOXONE;
TRAMADOL;
ANALGESIC ACTIVITY;
APRAXIA;
DEPERSONALIZATION;
DISORIENTATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG FORMULATION;
DRUG RECEPTOR BINDING;
DYSPHORIA;
HUMAN;
SHORT SURVEY;
WITHDRAWAL SYNDROME;
ANALGESICS, OPIOID;
APRAXIAS;
BUTORPHANOL;
DRUG INTERACTIONS;
HUMANS;
NARCOTIC ANTAGONISTS;
SUBSTANCE WITHDRAWAL SYNDROME;
|
|
EID: 0029785298
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|
